These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24582862)

  • 1. Interleukin-8 promotes canine hemangiosarcoma growth by regulating the tumor microenvironment.
    Kim JH; Frantz AM; Anderson KL; Graef AJ; Scott MC; Robinson S; Sharkey LC; O Brien TD; Dickerson EB; Modiano JF
    Exp Cell Res; 2014 Apr; 323(1):155-164. PubMed ID: 24582862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of canine hemangiosarcoma xenograft models expressing endothelial growth factors, their receptors, and angiogenesis-associated homeobox genes.
    Kodama A; Sakai H; Matsuura S; Murakami M; Murai A; Mori T; Maruo K; Kimura T; Masegi T; Yanai T
    BMC Cancer; 2009 Oct; 9():363. PubMed ID: 19825192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-12 inhibits tumor growth in a novel angiogenesis canine hemangiosarcoma xenograft model.
    Akhtar N; Padilla ML; Dickerson EB; Steinberg H; Breen M; Auerbach R; Helfand SC
    Neoplasia; 2004; 6(2):106-16. PubMed ID: 15140399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Sphingosine-1-phosphate (S1P)/S1P Receptor-1 Pathway with Cell Proliferation and Survival in Canine Hemangiosarcoma.
    Rodriguez AM; Graef AJ; LeVine DN; Cohen IR; Modiano JF; Kim JH
    J Vet Intern Med; 2015; 29(4):1088-97. PubMed ID: 26118793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic inhibition of MEK signaling prevents growth of canine hemangiosarcoma.
    Andersen NJ; Nickoloff BJ; Dykema KJ; Boguslawski EA; Krivochenitser RI; Froman RE; Dawes MJ; Baker LH; Thomas DG; Kamstock DA; Kitchell BE; Furge KA; Duesbery NS
    Mol Cancer Ther; 2013 Sep; 12(9):1701-14. PubMed ID: 23804705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between CXCR4 and CXCL12 promote cell migration and invasion of canine hemangiosarcoma.
    Im KS; Graef AJ; Breen M; Lindblad-Toh K; Modiano JF; Kim JH
    Vet Comp Oncol; 2017 Jun; 15(2):315-327. PubMed ID: 26337509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiling identifies inflammation and angiogenesis as distinguishing features of canine hemangiosarcoma.
    Tamburini BA; Phang TL; Fosmire SP; Scott MC; Trapp SC; Duckett MM; Robinson SR; Slansky JE; Sharkey LC; Cutter GR; Wojcieszyn JW; Bellgrau D; Gemmill RM; Hunter LE; Modiano JF
    BMC Cancer; 2010 Nov; 10():619. PubMed ID: 21062482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutive phosphorylation of the mTORC2/Akt/4E-BP1 pathway in newly derived canine hemangiosarcoma cell lines.
    Murai A; Asa SA; Kodama A; Hirata A; Yanai T; Sakai H
    BMC Vet Res; 2012 Jul; 8():128. PubMed ID: 22839755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological and molecular characterization of a canine hemangiosarcoma-derived cell line.
    Thamm DH; Dickerson EB; Akhtar N; Lewis R; Auerbach R; Helfand SC; MacEwen EG
    Res Vet Sci; 2006 Aug; 81(1):76-86. PubMed ID: 16256156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticancer effects of resveratrol in canine hemangiosarcoma cell lines.
    Carlson A; Alderete KS; Grant MKO; Seelig DM; Sharkey LC; Zordoky BNM
    Vet Comp Oncol; 2018 Jun; 16(2):253-261. PubMed ID: 29235249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemangiosarcoma cells induce M2 polarization and PD-L1 expression in macrophages.
    Gulay KCM; Aoshima K; Maekawa N; Suzuki T; Konnai S; Kobayashi A; Kimura T
    Sci Rep; 2022 Feb; 12(1):2124. PubMed ID: 35136176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of procoagulant tissue factor expression in canine hemangiosarcoma cell lines.
    Witter LE; Gruber EJ; Lean FZ; Stokol T
    Am J Vet Res; 2017 Jan; 78(1):69-79. PubMed ID: 28029283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KDM2B promotes cell viability by enhancing DNA damage response in canine hemangiosarcoma.
    Gulay KCM; Aoshima K; Shibata Y; Yasui H; Yan Q; Kobayashi A; Kimura T
    J Genet Genomics; 2021 Jul; 48(7):618-630. PubMed ID: 34023294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-214 Promotes Apoptosis in Canine Hemangiosarcoma by Targeting the COP1-p53 Axis.
    Heishima K; Mori T; Sakai H; Sugito N; Murakami M; Yamada N; Akao Y; Maruo K
    PLoS One; 2015; 10(9):e0137361. PubMed ID: 26335793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic potential of endothelin inhibitors in canine hemangiosarcoma.
    Fukumoto S; Saida K; Sakai H; Ueno H; Iwano H; Uchide T
    Life Sci; 2016 Aug; 159():55-60. PubMed ID: 26835989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tenovin-6 induces the SIRT-independent cell growth suppression and blocks autophagy flux in canine hemangiosarcoma cell lines.
    Igase M; Fujiki N; Shibutani S; Sakai H; Noguchi S; Nemoto Y; Mizuno T
    Exp Cell Res; 2020 Mar; 388(1):111810. PubMed ID: 31891684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour necrosis factor-related apoptosis-inducing ligand induces apoptosis in canine hemangiosarcoma cells in vitro.
    Goto M; Owaki K; Hirata A; Yanai T; Sakai H
    Vet Comp Oncol; 2019 Sep; 17(3):285-297. PubMed ID: 30767429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro effects of PI3K/mTOR inhibition in canine hemangiosarcoma.
    Pyuen AA; Meuten T; Rose BJ; Thamm DH
    PLoS One; 2018; 13(7):e0200634. PubMed ID: 30011343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of histone lysine demethylase 2B in canine hemangiosarcoma is associated with disease progression.
    Gulay KCM; Aoshima K; Kim S; Kitaguchi R; Kobayashi A; Kimura T
    Vet Comp Oncol; 2022 Jun; 20(2):529-534. PubMed ID: 34927338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of inhibitors of vascular endothelial growth factor receptor 2 and downstream pathways of receptor tyrosine kinases involving phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin or mitogen-activated protein kinase in canine hemangiosarcoma cell lines.
    Adachi M; Hoshino Y; Izumi Y; Sakai H; Takagi S
    Can J Vet Res; 2016 Jul; 80(3):209-16. PubMed ID: 27408334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.